It's part two of our discussion about the role of accelerators. This time our panel explore the importance of investment and financial backing in accelerator programmes, the role of investment in scaling ventures. They also cover the need for capital to succeed, the connection between accelerators and venture capital firms, and the impact of financial support on the success of programmes.

A reminder of our expert panelists:

Cristina Lisii​​​​ - Senior Programme Manager, The Royal Academy of Engineering

Bartosz Wawrzynów - Portfolio Manager, FNP Ventures

Oliver Rätsep - Head of Business Development, Accelerate Estonia

Oxentia's Head of Entrepreneurship, Fabio Bianchi facilitates the discussion.

Timestamps

The Importance of Investment in Acceleration Programs (00:00:57)

The Concept of 'Sell Before You Make' (00:03:39)

The Role of Accelerators in MedTech and Highly Regulated Spaces (00:05:37)

Measuring the Impact of Acceleration Programs (00:10:40)

The Role of Corporate Accelerators (00:13:54)

Closing Remarks (00:19:05)

Contact us with any questions at ideaspod@oxentia.com

#acceleratorprogrammes #accelerators #roleofaccelerators #acceleratorprograms

Hosted on Acast. See acast.com/privacy for more information.

What is the role of accelerators? How does this differ across innovation ecosystems and countries? Are there common formats to accelerator programmes, and how can programmes be tailored to deliver the optimum results for their participants?

Welcome to our two-part exploration of accelerators with three special guests including:

Cristina Lisii​​​​ - Senior Programme Manager, The Royal Academy of Engineering

Bartosz Wawrzynów - Portfolio Manager, FNP Ventures

Oliver Rätsep - Head of Business Development, Accelerate Estonia

Oxentia's Head of Entrepreneurship, Fabio Bianchi facilitates the discussion and we hope you'll enjoy listening to the different perspectives.

Timestamps

The role of accelerators in de-risking growth (00:05:45)

Accelerators as a facilitator for overcoming regulatory barriers (00:08:11)

The vital role of accelerators in catalyzing growth (00:10:06)

The timestamp's title (00:10:57)

The Cost of Accelerators (00:12:00)

Specialisation of Accelerators (00:14:24)

The cohort benefits vs. personal/tailor-made approach (00:22:09)

The importance of mentors and coachability (00:23:22)

The need for careful selection and understanding of venture capital (00:25:43)

Contact us with any questions at ideaspod@oxentia.com

Episode transcript

#acceleratorprogrammes #accelerators #roleofaccelerators #acceleratorprograms

Hosted on Acast. See acast.com/privacy for more information.

Where do you start when developing a new lateral flow test for early detection of prostate cancer, especially when you don't have full access to a lab?

In this episode of Bringing new ideas to life, Sarah Allison interviews Tiffany Ma, CEO and co-founder of GambitBio. Tiffany explains how Gambit Bio is developing a self-test kit for early cancer detection using saliva. Inspired by the accessibility of self-testing during the COVID-19 pandemic, Tiffany and her co-founders aim to make cancer detection easier and more accessible.

Listen to how Gambit took shape, the startup challenges encountered and the exciting plans for the future.

Timestamps

The idea behind Gambit Bio [00:01:17] Explanation the inspiration behind GambitBio, a startup developing a self-test kit for early cancer detection.

The innovation: a home self-test kit for cancer detection [00:02:22] The innovation behind GambitBio, a home self-test kit for early cancer detection using saliva as a sample.

Challenges and funding [00:08:32] The challenges of starting a startup without lab support and explains how they gathered funds through angel funding, competitions, and accelerator programmes.

Advice for starting a startup [00:14:01] Tiffany shares her advice for starting a startup, including the importance of taking action and seeking advice from people who have been in your shoes.

Future plans for Gambit Bio [00:15:32] Tiffany discusses her plans to raise money for Gambit Bio's seed round and bring a self-test kit for prostate cancer to the market, with the goal of expanding to other cancer types in the future.

Sarah Allison, is a Senior Consultant, Tiffany Ma, CEO GambitBio

Contact us with any questions at ideaspod@oxentia.com

Episode transcript

Hosted on Acast. See acast.com/privacy for more information.